Teza Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,579
| Closed | -$267K | – | 324 |
|
|
2025
Q1 | $267K | Sell |
35,579
-12,295
| -26% | -$92.2K | 0.12% | 291 |
|
|
2024
Q4 | $360K | Sell |
47,874
-4,864
| -9% | -$36.6K | 0.05% | 333 |
|
|
2024
Q3 | $401K | Sell |
52,738
-8,937
| -14% | -$67.9K | 0.04% | 432 |
|
|
2024
Q2 | $381K | Buy |
61,675
+16,640
| +37% | +$103K | 0.05% | 406 |
|
|
2024
Q1 | $229K | Buy |
45,035
+7,615
| +20% | +$38.7K | 0.03% | 489 |
|
|
2023
Q4 | $224K | Buy |
37,420
+18,968
| +103% | +$114K | 0.04% | 475 |
|
|
2023
Q3 | $131K | Buy |
18,452
+2,090
| +13% | +$14.8K | 0.02% | 554 |
|
|
2023
Q2 | $115K | Buy |
+16,362
| New | +$115K | 0.02% | 539 |
|